Reveal Biosciences is creating a new generation of data powered pathology to enhance research and improve global healthcare.
Cancer has impacted the lives of many of our friends and family. Reveal was founded in 2012 by Claire Weston and Casey Laris with a vision towards pathology driven by data. Our team is creating artificial intelligence technologies for whole slide pathology images that increase accuracy, reproducibility and scale. If the technology we’re building today had been available 15 years ago, a cancer misdiagnosis in Casey’s own family would likely have been caught. We see that by taking a quantitative approach, the data generated by our tools benefits preclinical research, clinical trials, and ultimately patients.
We are proud to partner with the following organizations
Latest research, in the news, or at events.
Precision medicine has come a long way towards benefiting patient outcomes and enhancing research tools. In recent years, the integration of multi-scale omics from genomic, proteomic, and transcriptomic foundations
Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general